Dominique Monnet - Net Worth and Insider Trading

Dominique Monnet Net Worth

The estimated net worth of Dominique Monnet is at least $3 Million dollars as of 2024-12-27. Dominique Monnet is the President and CEO of PDL BioPharma Inc and owns about 734,921 shares of PDL BioPharma Inc (PDLI) stock worth over $2 Million. Dominique Monnet is also the SVP, Chief Marketing Officer of Alexion Pharmaceuticals Inc and owns about 8,787 shares of Alexion Pharmaceuticals Inc (ALXN) stock worth over $2 Million. Details can be seen in Dominique Monnet's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Dominique Monnet has not made any transactions after 2020-12-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Dominique Monnet

To

Dominique Monnet Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Dominique Monnet owns 3 companies in total, including PDL BioPharma Inc (PDLI) , Evofem Biosciences Inc (EVFM) , and Alexion Pharmaceuticals Inc (ALXN) .

Click here to see the complete history of Dominique Monnet’s form 4 insider trades.

Insider Ownership Summary of Dominique Monnet

Ticker Comapny Transaction Date Type of Owner
PDLI PDL BioPharma Inc 2020-12-16 President and CEO
EVFM Evofem Biosciences Inc 2019-06-10 director
ALXN Alexion Pharmaceuticals Inc 2015-05-20 SVP & Chief Marketing Officer

Dominique Monnet Latest Holdings Summary

Dominique Monnet currently owns a total of 2 stocks. Among these stocks, Dominique Monnet owns 734,921 shares of PDL BioPharma Inc (PDLI) as of December 16, 2020, with a value of $2 Million and a weighting of 53.09%. Dominique Monnet also owns 8,787 shares of Alexion Pharmaceuticals Inc (ALXN) as of May 20, 2015, with a value of $2 Million and a weighting of 46.91%.

Latest Holdings of Dominique Monnet

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PDLI PDL BioPharma Inc 2020-12-16 734,921 2.47 1,815,255
ALXN Alexion Pharmaceuticals Inc 2015-05-20 8,787 182.50 1,603,628

Holding Weightings of Dominique Monnet


Dominique Monnet Form 4 Trading Tracker

According to the SEC Form 4 filings, Dominique Monnet has made a total of 1 transactions in PDL BioPharma Inc (PDLI) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in PDL BioPharma Inc is the sale of 500,000 shares on December 16, 2020, which brought Dominique Monnet around $1 Million.

According to the SEC Form 4 filings, Dominique Monnet has made a total of 0 transactions in Alexion Pharmaceuticals Inc (ALXN) over the past 5 years. The most-recent trade in Alexion Pharmaceuticals Inc is the sale of 256 shares on May 20, 2015, which brought Dominique Monnet around $41,574.

Insider Trading History of Dominique Monnet

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Dominique Monnet Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Dominique Monnet Ownership Network

Ownership Network List of Dominique Monnet

No Data

Ownership Network Relation of Dominique Monnet

Insider Network Chart

Dominique Monnet Owned Company Details

What does PDL BioPharma Inc do?

Who are the key executives at PDL BioPharma Inc?

Dominique Monnet is the President and CEO of PDL BioPharma Inc. Other key executives at PDL BioPharma Inc include VP & Gen. Counsel & Secretary Christopher Lewis Stone , VP Finance & CAO and Acting CFO Edward Imbrogno , and VP & Business Development Jill M. Jene .

PDL BioPharma Inc (PDLI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of PDL BioPharma Inc (PDLI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of PDL BioPharma Inc (PDLI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

PDL BioPharma Inc (PDLI)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

PDL BioPharma Inc Insider Transactions

No Available Data

Dominique Monnet Mailing Address

Above is the net worth, insider trading, and ownership report for Dominique Monnet. You might contact Dominique Monnet via mailing address: C/o Alexion Pharmaceuticals, Inc., 352 Knotter Drive, Cheshire Ct 06410.

Discussions on Dominique Monnet

No discussions yet.